Home / Import refusals / 799-6241705-2/11/1

FDA Import Refusal 799-6241705-2/11/1 — Glaxo India

Glaxo India — FEI 3000146207

The FDA refused shipment 799-6241705-2/11/1 from Glaxo India (India) on March 14, 2025. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 14, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61JDA16 ROSUVASTATIN CALCIUM
Charges
75

Other import refusals

  • 1FX-7030224-4/10002/1 (Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6241705-2/71/1 (Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6241705-2/71/2 (Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9303794-3/11/1 (Wed Jun 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-4874980-4/1/2 (Fri Apr 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources